Literature DB >> 19618231

Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.

Johannes Carolus Magnus Schlachetzki1, Klaus Schmidtke, Jan Beckervordersandforth, Wiktor Borozdin, Christian Wilhelm, Michael Hüll, Jürgen Kohlhase.   

Abstract

Mutations of the progranulin gene lead to progranulin haploinsufficiency and to frontotemporal lobar degeneration (FTD) with TDP-43 positive inclusions. It is assumed that unknown genetic, epigenetic and environmental factors are responsible for the observed marked degree of phenotypic variability among mutation carriers. This is the first published series of German FTD cases screened for progranulin mutations. Mean age at onset was 62 years, 19 patients (24%) had a positive family history of dementia, and 11 patients (14%) had a positive family history for probable FTD. Data on FTD subtypes are presented. Two mutations were identified (3%), one of which has been described previously. Clinically, both patients showed the frontal-behavioural variant type of FTD. Remarkably, a sibling of one case presented with progressive nonfluent aphasia, clinically distinct from the brother. We also performed quantitative PCR analyses to detect potential whole progranulin gene and exon deletions. Here, results were negative.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618231     DOI: 10.1007/s00415-009-5248-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

2.  Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo.

Authors:  Z He; A Bateman
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

Review 3.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

Review 5.  Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Curr Alzheimer Res       Date:  2006-12       Impact factor: 3.498

6.  Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.

Authors:  Adolfo López de Munain; Ainhoa Alzualde; Ana Gorostidi; David Otaegui; Javier Ruiz-Martínez; Begoña Indakoetxea; Isidro Ferrer; Jordi Pérez-Tur; Amets Sáenz; Alberto Bergareche; Miriam Barandiarán; Juan José Poza; Ramón Zabalza; Irune Ruiz; Miguel Urtasun; Iñaki Fernández-Manchola; Bixen Olasagasti; Juan Bautista Espinal; Javier Olaskoaga; Marta Ruibal; Fermin Moreno; Nieves Carrera; José Félix Martí Massó
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

7.  Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease.

Authors:  Anne Rovelet-Lecrux; Vincent Deramecourt; Solenn Legallic; Claude-Alain Maurage; Isabelle Le Ber; Alexis Brice; Jean-Charles Lambert; Thierry Frébourg; Didier Hannequin; Florence Pasquier; Dominique Campion
Journal:  Neurobiol Dis       Date:  2008-04-07       Impact factor: 5.996

8.  Corticobasal syndrome associated with the A9D Progranulin mutation.

Authors:  Salvatore Spina; Jill R Murrell; Edward D Huey; Eric M Wassermann; Pietro Pietrini; Jordan Grafman; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

9.  Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.

Authors:  Vivianna M Van Deerlin; Elisabeth McCarty Wood; Peachie Moore; Wuxing Yuan; Mark S Forman; Christopher M Clark; Manuela Neumann; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee; Murray Grossman
Journal:  Arch Neurol       Date:  2007-08

10.  Familial aggregation in frontotemporal dementia.

Authors:  M Stevens; C M van Duijn; W Kamphorst; P de Knijff; P Heutink; W A van Gool; P Scheltens; R Ravid; B A Oostra; M F Niermeijer; J C van Swieten
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  3 in total

1.  Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells.

Authors:  Goang-Won Cho; Byung Yong Kang; Seung Hyun Kim
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

Review 2.  [Frontotemporal dementias].

Authors:  K Witt; G Deuschl; T Bartsch
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

3.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.